Alle Studien
RekrutierungPHASE1, PHASE2INTERVENTIONELL

Eine Studie zur Bewertung von BMS-986470 bei gesunden Freiwilligen und Teilnehmern mit Sichelzellenanämie

Sickle cell disease is an inherited blood condition that causes red blood cells to change shape and block blood vessels, leading to severe pain and organ damage. This early-stage clinical trial is testing a new investigational drug called BMS-986470. The study has two main groups. The first group includes healthy adult volunteers to see how safe the drug is, how the body absorbs it, and how food or common stomach medicines affect it. The second group includes adults with sickle cell disease who have had frequent painful episodes, known as vaso-occlusive crises, over the past year. Researchers will closely monitor participants' blood, heart, and general health to see whether the drug helps improve blood flow and reduce painful attacks. Some participants may receive a dummy drug (placebo) to help compare results fairly.

Auf einen Blick

Status
Rekrutierung
Phase
PHASE1, PHASE2
Sponsor
Bristol-Myers Squibb
Einschreibeziel
224
Starten
17. Juli 2024
Geschätzte Fertigstellung
16 Nov 2027

Worum geht es in dieser Studie?

Sickle cell disease affects red blood cells, which carry oxygen around the body. In people with the condition, these cells can become hard and curved, like a crescent moon or sickle. These sticky cells can get stuck in small blood vessels, blocking blood flow. This causes sudden, intense pain known as a sickle cell crisis or vaso-occlusive crisis, and can lead to long-term organ damage.

This trial is looking at an experimental medicine called BMS-986470. Scientists want to know whether this medicine is safe to take and whether it might help prevent blood cells from sticking together and causing crises. Before a medicine can be widely used, doctors must run careful tests to understand how it behaves inside the body.

To do this, the trial involves two sets of people. Healthy volunteers will take the medicine to help doctors measure how it is absorbed into the bloodstream, how it breaks down, and whether meals or common indigestion tablets (like famotidine or pantoprazole) change how it works. People living with sickle cell disease will also test the medicine to see if it shows early signs of improving blood counts and reducing painful episodes.

Finding new, effective treatments for sickle cell disease is vital. Current treatment options are limited, and many people still suffer from unpredictable, severe pain. By joining this research, participants help doctors learn whether this new approach could become a helpful future treatment.

Wichtige Erkenntnisse

  • Tests an early-stage experimental medicine (BMS-986470) for sickle cell disease.
  • Open to both healthy volunteers and adults diagnosed with sickle cell disease.
  • Aims to check the drug's safety, how it breaks down in the body, and its effect on painful crises.
  • Involves clinic visits, blood tests, and heart monitoring (ECGs).
  • Participation is entirely voluntary, and you can stop at any time.

Wer könnte berechtigt sein?

This study is open to adults aged 18 and older who fall into one of two groups. The first group is for healthy volunteers. To join this group, you must be in generally good health, have a healthy body weight (BMI between 18 and 32), and have no major organ problems. Women in this healthy group must not be able to have children (for example, having gone through the menopause or had surgery preventing pregnancy).

The second group is for people who have been diagnosed with specific types of sickle cell disease (such as HbSS or certain sickle beta-thalassaemia types). Participants in this group must have had at least two to four painful crises in the past 6 to 12 months that needed medical attention. They must also have blood test results that fall within safe limits set by the study team.

You cannot take part in the healthy volunteer group if you have any significant ongoing medical conditions, recent major surgery, or abnormal lab results that could make joining unsafe. People with sickle cell disease will also be checked carefully to ensure their kidneys, liver, and blood counts are stable enough for the trial.

Könnte diese Studie für Sie geeignet sein?

Beantworten Sie diese kurzen Fragen, um zu sehen, ob Sie möglicherweise berechtigt sind. Dies ist nur ein Leitfaden – das Forschungsteam trifft die endgültige Entscheidung.

  1. Are you aged 18 or older?
  2. Are you either in good general health, OR living with diagnosed sickle cell disease?
  3. If you have sickle cell, have you had at least 2 to 4 painful crises in the past year?
  4. Are you willing to attend regular clinic visits and have blood tests taken?
  5. If you are a healthy female volunteer, are you post-menopausal or surgically sterile?
Beantworten Sie jede Frage, um Ihr Ergebnis zu sehen.

Was beinhaltet die Teilnahme?

Taking part in this trial involves several in-person hospital or clinic visits. At the start, you will attend a screening visit where doctors check your medical history, perform a physical exam, test your heart with an ECG, and take blood and urine samples to make sure you are safe to join. Depending on your group, you will take the study drug, BMS-986470, as a tablet or liquid. Some participants may be given a placebo (a dummy treatment with no active ingredients) or common stomach acid tablets to see if they change how the drug works. You may need to stay overnight at the clinic for certain monitoring periods so staff can take blood samples at set times after you take the medicine. Throughout the study, doctors will track any side effects and watch how your health responds. The total duration of your participation will be discussed with you before you agree to take part.

Potenzielle Risiken und Vorteile

There is no guarantee that taking part will directly improve your health, especially if you are in the healthy group or receive a placebo. However, participants with sickle cell disease might see improvements in their symptoms, and everyone who takes part helps advance scientific research for future patients. Potential risks include side effects from the new medicine, which could range from mild stomach upsets or headaches to unexpected reactions. Blood tests may cause minor bruising or discomfort. Taking part is completely voluntary, and you are free to leave the study at any time without giving a reason and without it affecting your standard NHS care.

Standorte (32)

Einige Standortangaben sind ungefähr. Wir arbeiten daran, dies zu verbessern — bitte überprüfen Sie die Angaben mit dem Versuchsteam, bevor Sie reisen.
  • Universität von Alabama in Birmingham
    Verifizierte Postleitzahl
    Birmingham, Vereinigte Staaten· Rekrutierung
  • University of California San Diego - La Jolla
    Verifizierte Postleitzahl
    La Jolla, Vereinigte Staaten· Rekrutierung
  • UCSF Benioff Children's Hospital Oakland
    Verifizierte Postleitzahl
    Oakland, Vereinigte Staaten· Rekrutierung
  • Yale-New Haven Hospital
    Verifizierte Postleitzahl
    New Haven, Vereinigte Staaten· Rekrutierung
  • Winship Cancer Institute of Emory University
    Verifizierte Postleitzahl
    Atlanta, Vereinigte Staaten· Rekrutierung
  • Local Institution - 0034
    Verifizierte Postleitzahl
    Chicago, Vereinigte Staaten· Noch nicht rekrutiert
  • Local Institution - 0001
    Verifizierte Postleitzahl
    Lenexa, United States· Aktiv, aber nicht rekrutierend
  • Local Institution - 0064
    Verifizierte Postleitzahl
    Baltimore, Vereinigte Staaten· Noch nicht rekrutiert
  • Local Institution - 0024
    Verifizierte Postleitzahl
    Boston, Vereinigte Staaten· Noch nicht rekrutiert
  • Boston Medical Center
    Verifizierte Postleitzahl
    Boston, Vereinigte Staaten· Rekrutierung
  • Local Institution - 0030
    Verifizierte Postleitzahl
    St. Louis, Vereinigte Staaten· Noch nicht rekrutiert
  • Local Institution - 0033
    Verifizierte Postleitzahl
    Greenville, Vereinigte Staaten· Noch nicht rekrutiert

Häufige Fragen

Was ist ein Placebo?

A placebo is a dummy treatment designed to look just like the real medicine but containing no active drug. Comparing it to the real medicine helps researchers see whether changes are truly caused by the new drug.

Will taking part cost me anything?

No, the study medicine and all related tests are provided free of charge. Travel expenses to and from the clinic are usually reimbursed.

Can I carry on taking my usual medicines?

Some medicines, like hydroxyurea, may be allowed if your dose has been steady. The study doctor will review all your current prescriptions to check if they are safe to take during the trial.

What happens if I feel unwell during the study?

You will be given contact details for the medical team, who are available 24 hours a day. If you feel unwell, you should contact them straight away or seek urgent medical care if needed.

Can I leave the trial if I change my mind?

Yes. You can withdraw your consent and leave the study at any point. Your decision will not change your relationship with your doctors or the quality of your regular medical treatment.

Wie Sie mehr erfahren können

BMS Clinical Trials Contact Center www.BMSClinicalTrials.com

Sprechen Sie immer mit Ihrem Hausarzt oder Spezialisten, bevor Sie sich entscheiden, an einer Studie teilzunehmen.

Interessiert daran, teilzunehmen?

Registrieren Sie Ihr Interesse

Teilen Sie Ihre Details und das Forschungsteam für "A Study to Evaluate BMS-986470 in Healthy Volunteers and Par… wird Sie kontaktieren, wenn Sie möglicherweise infrage kommen. Sprechen Sie immer mit Ihrem Hausarzt, bevor Sie zustimmen, teilzunehmen.

Diskussion

Community-Diskussion

Bereitgestellt von unserem Forum bei community.patient.info. Bitte seien Sie respektvoll — dies ist kein medizinischer Rat.